Tanja Stocks

Medicine & Life Sciences

1. Metabolic Syndrome 100%
2. Body Mass Index 73%
3. Neoplasms 66%
4. Blood Pressure 48%
5. Confidence Intervals 43%
6. Prostatic Neoplasms 42%
7. Prospective Studies 42%
8. Triglycerides 38%
9. Obesity 37%
10. Cohort Studies 31%
11. Glucose 22%
12. Weights and Measures 21%
13. Urinary Bladder Neoplasms 21%
14. Cholesterol 20%
15. Mortality 20%
16. Sweden 20%
17. Overweight 19%
18. Breast Neoplasms 18%
19. Body Size 17%
20. Smoking 17%
21. Population 17%
22. Austria 16%
23. Weight Gain 16%
24. Blood Glucose 14%
25. Thinness 14%
26. Proportional Hazards Models 13%
27. Dietary Proteins 12%
28. Insulin Resistance 12%
29. Serum 11%
30. Liver Neoplasms 11%
31. Hypertension 11%
32. Weight Loss 11%
33. Mendelian Randomization Analysis 10%
34. Incidence 10%
35. Life Style 10%
36. Melanoma 10%
37. Survival Analysis 9%
38. Norway 9%
39. Alcohol Drinking 9%
40. Adenocarcinoma 9%
41. Pancreatic Neoplasms 9%
42. Fats 8%
43. Gallbladder Neoplasms 8%
44. Colorectal Neoplasms 8%
45. Leptin 8%
46. Diet 8%
47. Transcription Factor AP-2 8%
48. Hyperglycemia 8%
49. Urinary Bladder Diseases 7%
50. Gonadal Steroid Hormones 7%